Yoshiyuki Suzuki

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi et al. · Hepatology · 2012 · 700 citations · Full text

Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection

Hiromitsu Kumada, Yoshiyuki Suzuki, Kenji Ikeda et al. · Hepatology · 2014 · 538 citations · Full text

Endogenous non-retroviral RNA virus elements in mammalian genomes

Masayuki Horie, Tomoyuki Honda, Yoshiyuki Suzuki et al. · Nature · 2010 · 483 citations

Viral Replication, Genetics, Molecular Biology +5

Effect of Interferon Therapy on Hepatocellular Carcinogenesis in Patients With Chronic Hepatitis Type C: A Long–Term Observation Study of 1,643 Patients Using Statistical Bias Correction With Proportional Hazard Analysis

Kenji Ikeda, Satoshi Saitoh, Yasuji Arase et al. · Hepatology · 1999 · 465 citations · Full text

Immunology, Pathology, Statistical Bias Correction +21

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9